Increased activity of antithymus serum after absorption with splenic lymphocytes.
D000042:Absorption; D000818:Animals; D000961:Antilymphocyte Serum; D001835:Body Weight; D006086:Graft vs Host Disease / Q000209:etiology; D007106:Immune Sera / Q000494:pharmacology*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007958:Leukocyte Count; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D051379:Mice; D011817:Rabbits; D013154:Spleen / Q000166:cytology*; D013950:Thymus Gland / Q000033:anatomy & histology / Q000166:cytology / Q000276:immunology*
D000961:Antilymphocyte Serum; D007106:Immune Sera; D007166:Immunosuppressive Agents